In a randomized clinical trial, researchers from Huntsman Cancer Institute at the University of Utah (the U) have found that ...

Pfizer has ended development of a B7-H4-directed antibody-drug conjugate (ADC), triggering a $1 billion impairment charge. | ...

Drs Ursula A. Matulonis and Eloise Chapman-Davis discuss overcoming health disparities in endometrial cancer and increasing clinical trial enrollment of Black women.

HOUSTON - Bio-Path Holdings, Inc. (NASDAQ:BPTH), a biotechnology company with a market capitalization of $3.1 million, has announced continued progress in its clinical trials for cancer treatments.

Researchers have found that fewer sessions of higher dose vaginal cuff brachytherapy work just as well as more frequent, lower-dose treatments for endometrial cancer patients.

Compared with chemotherapy alone, the addition of radiation to chemotherapy did not improve overall or recurrence-free survival in patients with locally advanced endometrial cancer, a new phase 3 ...

The high prevalence of sarcopenia in patients with ovarian and endometrial cancers underscores the importance of early ...

While part 1A (dose escalation) determined the recommended dose of INCB123667 for expansion and the maximum tolerated dose ...